A recent study shows that nano-curcumin, as an anti-inflammatory herbal-based agent, modulates the increase of inflammatory cytokines, especially serum IL-1β and IL-6 mRNA expression and cytokine secretion in COVID-19 patients, which may reflect an improvement in clinical manifestation and overall recovery [45]. The gene discussed is IL1B; the disease is COVID-19.